The 7 analysts offering 12-month price forecasts for Amarin Corporation PLC have a median target of 10.00, with a high estimate of 10.00 and a low estimate of 3.00. The median estimate represents a +214.47% increase from the last price of 3.18.
Correspondingly, Is AMRN a good stock? Amarin Corporation PLC finds support from accumulated volume at $3.26 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested. This stock has average movements during the day and with good trading volume, the risk is considered to be medium.
What is the future for Amarin? Consensus from 9 of the American Biotechs analysts is that Amarin is on the verge of breakeven. They anticipate the company to incur a final loss in 2021, before generating positive profits of US$11m in 2022. The company is therefore projected to breakeven around 12 months from now or less.
Furthermore, Is Amarin undervalued?
Amarin stock is pretty undervalued at the moment. The company has a cash balance of $521.3 million and no debt, giving it an enterprise value (EV) of just $1.23 billion — leaving it an EV-to-sales multiple of just two.
Is Amarin a good company?
Is Amarin a good company to work for? Amarin has an overall rating of 3.7 out of 5, based on over 94 reviews left anonymously by employees. 55% of employees would recommend working at Amarin to a friend and 21% have a positive outlook for the business. This rating has decreased by -9% over the last 12 months.
